Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 140, 2020 - Issue 7
Submit an article Journal homepage
162
Views
3
CrossRef citations to date
0
Altmetric
Larynx

RETRACTED ARTICLE: Neoadjuvant chemotherapy as a comprehensive treatment in patients with laryngeal and hypopharyngeal carcinoma

Xian-Feng WeiDepartment of Otorhinolaryngology Head and Neck, Tianjin First Central Hospital, Tianjin, China;
,
Akanksha SrivastavaDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Peng LinDepartment of Otorhinolaryngology Head and Neck, Tianjin First Central Hospital, Tianjin, China;
,
Li LiDepartment of Otorhinolaryngology Head and Neck, Tianjin First Central Hospital, Tianjin, China;
,
Shengchi ZhangDepartment of Otorhinolaryngology Head and Neck, Tianjin First Central Hospital, Tianjin, China;
,
Xin PengDepartment of Otorhinolaryngology Head and Neck, Tianjin First Central Hospital, Tianjin, China;
,
Chuan LiuDepartment of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;
,
Limei LiuDepartment of Ophthalmology, Yuhuangding Hospital of Qingdao University, Yantai, China; Correspondence[email protected]
,
Li-rong WuDepartment of Radiation Oncology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China; Correspondence[email protected]
,
Guo-jun LiDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA;
&
Yun-Cheng LiDepartment of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4523-6589
ORCID Icon show all
Pages i-vii | Received 07 Jan 2020, Accepted 25 Feb 2020, Published online: 18 Mar 2020

References

  • Wolf GT, Fisher SG, Hong WK, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685–1690.
  • Bar-Ad V, Palmer J, Yang H, et al. Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatments. Semin Oncol. 2014;41(6):798–806.
  • Eisenberger M, Hornedo J, Silva H, et al. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1986;4(10):1506–1509.
  • Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12(2):153–159.
  • Yamaoka H, Tsukuda M, Enomoto H, et al. [Effect of combination chemotherapy with nedaplatin and 5-FU for head and neck squamous cell carcinoma]. Gan to Kagaku Ryoho Cancer Ryoho. 2001;28(9):1245–1249.
  • Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695–1704.
  • Lowe NM, Bernstein JM, Mais K, et al. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status. J Cancer Res Clin Oncol. 2018;144(2):389–401.
  • Barbour AP, Jones M, Gonen M, et al. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Ann Surg Oncol. 2008;15(10):2894–2902.
  • Zum Buschenfelde CM, Herrmann K, Schuster T, et al. (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial. J Nucl Med. 2011;52(8):1189–1196.
  • Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–578.
  • Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101(7):498–506.
  • Wang HM, Lin CY, Hsieh CH, et al. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. J Nucl Med. 2017;116(3):185–192.
  • Demirci NS, Aksoy S, Ozdemir NY, et al. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study. Curr Med Res Opin. 2017;33(3):401–407.
  • Cho H, Nishiike S, Yamamoto Y, et al. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma. Auris Nasus Larynx. 2015;42(5):396–400.
  • Worden FP, Moyer J, Lee JS, et al. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope. 2009;119(8):1510–1517.
  • Chaigneau L, Guardiola E, N’Guyen T, et al. [Induction chemotherapy in patients with head and neck cancer]. Bull Cancer. 2006;93(7):677–682.
  • Nakahara S, Takenaka Y, Ogawa K, et al. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma. Int J Clin Oncol. 2016;21(6):1030–1037.
  • Denaro N, Russi EG, Merlano MC. Pros and cons of the new edition of TNM classification of head and neck squamous cell carcinoma. Oncology. 2018;95(4):202–210.
  • Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357(17):1705–1715.
  • Ohashi T, Ohnishi M, Tanahashi S, et al. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer. Jpn J Clin Oncol. 2011;41(3):348–352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.